Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...

New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

Thanks to the increasing availability of point-of-care (POC) testing, the use of capillary blood (fingerstick) sampling worldwide is growing. Anemia affects around 25% of the global population. Its ...

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

BD is expanding its long-running partnership with the blood collection company Babson Diagnostics, which aims to make taking a high-quality sample in pharmacies, grocery stores or at home as easy as ...

Virtually painless approach, leveraging HALO technology™, improves patient access, affordability, and accuracy in decentralized clinical trials with greater flexibility for health and wellness testing ...

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...